Recent developments with Guardant Health Inc (GH) have led to the company’s beta value being reach 1.40 cents.

on Tuesday, Guardant Health Inc (NASDAQ: GH) opened higher 3.08% from the last session, before settling in for the closing price of $38.00. Price fluctuations for GH have ranged from $20.14 to $52.92 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 28.17%. Company’s average yearly earnings per share was noted 22.02% at the time writing. With a float of $117.62 million, this company’s outstanding shares have now reached $123.65 million.

The extent of productivity of a business whose workforce counts for 2021 workers is very important to gauge. In terms of profitability, gross margin is 61.34%, operating margin of -58.78%, and the pretax margin is -53.67%.

Guardant Health Inc (GH) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Guardant Health Inc is 5.06%, while institutional ownership is 96.39%. The most recent insider transaction that took place on May 19 ’25, was worth 4,645. In this transaction Director of this company sold 116 shares at a rate of $40.04, taking the stock ownership to the 3,479 shares. Before that another transaction happened on May 19 ’25, when Company’s Director proposed sale 116 for $40.04, making the entire transaction worth $4,645.

Guardant Health Inc (GH) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around 22.02% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.66% during the next five years compared to -33.61% drop over the previous five years of trading.

Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators

Check out the current performance indicators for Guardant Health Inc (GH). In the past quarter, the stock posted a quick ratio of 3.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.27.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -2.39 in one year’s time.

Technical Analysis of Guardant Health Inc (GH)

The latest stats from [Guardant Health Inc, GH] show that its last 5-days average volume of 1.67 million was inferior to 2.34 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 33.82%. Additionally, its Average True Range was 2.27.

During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 39.61%, which indicates a significant increase from 39.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.33% in the past 14 days, which was lower than the 72.32% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $43.33, while its 200-day Moving Average is $35.13. Now, the first resistance to watch is $39.71. This is followed by the second major resistance level at $40.26. The third major resistance level sits at $40.88. If the price goes on to break the first support level at $38.54, it is likely to go to the next support level at $37.92. The third support level lies at $37.37 if the price breaches the second support level.

Guardant Health Inc (NASDAQ: GH) Key Stats

There are currently 123,888K shares outstanding in the company with a market cap of 4.85 billion. Presently, the company’s annual sales total 739,020 K according to its annual income of -436,370 K. Last quarter, the company’s sales amounted to 203,470 K and its income totaled -95,160 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.